n the surface, a pregnant woman and a person with cancer would seem to have little in common. But both may have DNA that isn’t the sequence they were born with floating around in their blood.

That DNA — from a fetus or a cancer — provides a potential target for new, non-invasive tests. Some researchers and companies are leveraging expertise in either circulating tumor DNA or non-invasive prenatal testing to develop tests in the other field.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.